Journal of Prevention and Treatment for Stomatological Diseases ›› 2019, Vol. 27 ›› Issue (5): 273-279.doi: 10.12016/j.issn.2096-1456.2019.05.001

• Expert Forum • Previous Articles     Next Articles

Evolution of diagnostic criteria for Sjögren′s Syndrome

TAO Qian(),LIANG Peisheng   

  1. Hospital of Stomatology, Guanghua School of Stomatology, Sun Yat-sen University, Guangdong Provincial Key Laboratory of Stomatology, Guangzhou 510055, China
  • Received:2018-11-04 Revised:2018-12-04 Online:2019-05-21 Published:2019-05-20

RichHTML

25

PDF (PC)

102

Abstract:

Sj?gren′s syndrome lacks a single and objective diagnostic index, and its diagnosis often requires comprehensive analysis according to classification criteria. With increasing research and a deepening understanding of the disease, the classification criteria are constantly being adjusted and revised. The sensitivity and specificity of the diagnosis have gradually improved, which has the value of diagnostic criteria largely. Since 1965, more than ten diagnostic criterias for Sj?gren′s syndrome have been published. After debate and experience, international criteria with wide applicability have gradually replaced regional criteria. In the evolution of the diagnostic criteria, the diagnostic rules and evaluation methods have become more concise and unified. Techniques with poor specificity and operative difficulty, which are not easy to popularize or apply in the clinic, have gradually been eliminated. A diagnostic system based on an objective examination and subjective symptoms has gradually formed, and lip gland biopsy and serum autoantibody sampling have demonstrated great diagnostic value. The optimization of diagnostic rules makes the diagnosis of this disease more efficient and scientific. This paper reviews the characteristics of and differences in diagnostic criteria for Sj?gren′s syndrome and analyzes the internal logic of the evolution of different diagnostic criteria in light of development in research on the disease with the hope of benefitting the diagnosis, treatment and related research of Sj?gren′s syndrome.

Key words: Sicca syndrome, Sj?gren′s syndrome, Primary Sj?gren′s syndrome, Secondary Sj?gren′s syndrome, Ocular staining score, Salivary flow rate, Diagnosis criteria, Classification criteria

CLC Number: 

  • R781.7

Common international classification criteria 1)"

项目 欧洲标准,1993[13] AECG标准,2002[14] ACR标准,2012[15] ACR/EULAR标准,2016[16]
Ⅰ眼部症状 有 有 无 无1）
Ⅱ口腔症状 有 有 无 无1）
Ⅲ眼部体征 Schirmer试验Ⅰ ≤ 5 mm/5 min ≤ 5 mm/5 min2） 无 ≤ 5 mm/5 min（1分）
角结膜染色 VBS ≥ 4 VBS ≥ 4 OSS ≥ 53） OSS ≥ 5或VBS ≥ 4（1分）
Ⅳ组织学检查 FS ≥ 1 FS ≥ 1 FS ≥ 1 FS ≥ 1（3分）
Ⅴ唾液腺检查 静息相唾液流率 ≤ 1.5 mL/15 min ≤ 1.5 mL/15 min2） 无 ≤ 0.5 mL/5 min（1分）
腮腺造影 有 有 无 无
核素扫描 有 有 无 无
Ⅵ血清学检查 抗SSA抗体和（或）
抗SSB抗体阳性		 抗SSA抗体和（或）
抗SSB抗体阳性		 [抗SSA抗体和（或）
抗SSB抗体阳性]
或[RF和ANA≥1：320]		 抗SSA抗体阳性（3分）
pSS诊断要求 6项至少符合4项 6项至少符合4项,
必须包括Ⅳ或Ⅵ项		 Ⅲ、Ⅳ、Ⅵ 3项中至少
符合2项		 赋值总分≥4分
sSS诊断要求 Ⅰ或Ⅱ符合1项,Ⅲ、Ⅳ、
Ⅴ3项中至少符合2项		 Ⅰ或Ⅱ符合1项,Ⅲ、Ⅳ、
Ⅴ3项中至少符合2项		 不适用于sSS

Table 2

Evolution of exclusion criteria"

分类（诊断）标准 排除标准
Bloch标准[5] 其他已知原因引起的唾液腺及泪腺疾病
圣地亚哥标准[8] 结节病、已存在的淋巴瘤、获得性免疫缺陷综合征及其他已知原因引起的角膜干燥或唾液腺肿大
欧洲标准[13] 结节病、已存在的淋巴瘤、获得性免疫缺陷综合征、移植物抗宿主病、服用抗乙酰胆碱药、服用抗抑郁药、服用降压药、服用抗精神病药
AECG标准[14] 既往头颈部放疗史、丙肝病毒感染、结节病、已存在的淋巴瘤、获得性免疫缺陷综合征、移植物抗宿主病、服用抗胆碱能药物（未达到药物半衰期4倍）
ACR标准[15] 既往头颈部放疗史、丙肝病毒感染、结节病、获得性免疫缺陷综合征、移植物抗宿主病、淀粉样变、IgG4相关性疾病
ACR/EULAR标准[16] 既往头颈部放疗史、活动性丙肝病毒感染（经PCR检查确认）、结节病、获得性免疫缺陷综合征、移植物抗宿主病、淀粉样变、IgG4相关性疾病

Figure 1

Parotid gland angiography based on three-dimensional CBCT reconstruction"

Figure 2

Saliva collection and flow rate measurement device for large salivary glands"

Table 3

Classification criteria for Sj?gren’s syndrome（AECG,2002）"

项目 内容
Ⅰ.口腔症状 3项中有1项或1项以上：①每日感口干持续3个月以上;②成年后腮腺反复或持续肿大;③吞咽干性食物时需用水帮助
Ⅱ.眼部症状 3项中有1项或1项以上：①每日感到不能忍受的眼干持续3个月以上;②有反复的砂子进眼或砂磨感觉;③每日需用人工泪液 3 次或 3 次以上
Ⅲ.眼部体征 下述检查任1项或1项以上阳性：①Schirmer试验（+）（≤5 mm/5 min）;②角膜染色（+）（≥4 VBS）
Ⅳ.组织学检查 下唇腺病理活检示淋巴细胞灶≥1
Ⅴ.涎腺受损 下述检查任1项或1项以上阳性：①唾液流率≤1.5 mL/15 min;②腮腺造影（+）;③涎腺同位素检查（+）
Ⅵ.自身抗体 抗SSA抗体或抗SSB抗体阳性（双扩散法）
具体分类 pSS 无任何潜在疾病的情况下,符合有下述任1条则可诊断：①符合4条或4条以上,但必须含有条目Ⅳ（组织学检查）和/或条目（自身抗体）;②条目Ⅲ、Ⅳ、Ⅴ、Ⅵ4 条中任3条阳性6项至少符合4项,必须包括Ⅳ或Ⅵ项
sSS 患者有潜在的疾病（如任一结缔组织病）,而符合Ⅰ和Ⅱ中任1条,同时符合条目Ⅲ、Ⅳ、Ⅴ中任2条
必须除外 颈头面部放疗,丙型肝炎病毒感染,获得性免疫缺陷综合征,淋巴瘤,结节病,移植物抗宿主病,抗乙酰胆碱药的应用（如阿托品 、莨菪碱 、溴丙胺太林、颠茄等）
[1] Sumida T, Azuma N, Moriyama M , et al. Clinical practice guideline for Sjögren′s syndrome 2017[J]. Mod Rheumatol, 2018,28(3):383-408.
[2] Sandhya P, Kurien BT, Danda D , et al. Update on pathogenesis of sjögren′s syndrome[J]. Curr Rheumatol Rev, 2017,13(1):5-22.
[3] Del Papa N, Vitali C . Management of primary Sjögren′s syndrome: recent developments and new classification criteria[J]. Ther Adv Musculoskelet Dis, 2018,10(2):39-54.
[4] Franceschini F, Cavazzana I, Andreoli LA . The 2016 classification criteria for primary Sjögren′s syndrome: what′s new?[J]. BMC Med, 2017,15(1):69.
[5] Bloch KJ, Buchanan WW, Wohl MJ , et al. Sjögren′s syndrome. A clinical, pathological, and serological study of sixty-two cases[J]. Medicine (Baltimore), 1965,44:187-231.
[6] Daniels TE, Jr SS, Michalski JP , et al. The oral component of Sjögren′s syndrome[J]. Oral Surg Oral Med Oral Pathol, 1975,39(6):875-885.
[7] Strand V, Talal N . Advances in the diagnosis and concept of Sjögren′s syndrome(autoimmune exocrinopathy)[J]. Bull Rheum Dis, 1979,30(9):1046.
pmid: 398729
[8] Fox RI, Robinson C, Curd J , et al. First international symposium on Sjögren′s syndrome: suggested criteria for classification[J]. Scand J Rheumatol Suppl, 1986,61:28-30.
pmid: 3473644
[9] Homma M, Tojo T, Akizuki M , et al. Criteria for sjogrens-syndrome in Japan[J]. Scand J Rheumatol, 1986,61:26-27.
doi: 10.1007/BF00541318
[10] Manthorpe R, Oxholm P, Prause JU , et al. The Copenhagen criteria for Sjögren′s syndrome[J]. Scand J Rheumatol, 1986,61:19-21.
doi: 10.1007/BF00541318 pmid: 3473631
[11] Prause JU, Manthorpe R, Oxholm P , et al. Definition and criteria for Sjögren′s syndrome used by the contributors to the First International Seminar on Sjögren′s syndrome—1986[J]. Scand J Rheumatol Suppl, 1986,61:17-18.
doi: 10.1002/(SICI)1096-9853(19991210)23:14<1733::AID-NAG992>3.0.CO;2-L pmid: 3473628
[12] Skopouli FN, Drosos AA, Papaioannou T , et al. Preliminary diagnostic criteria for Sjögren′s syndrome[J]. Scand J Rheumatol Suppl, 1986,61:22-25.
doi: 10.1016/S0140-6736(99)02251-5 pmid: 3473635
[13] Vitali C, Bombardieri S, Moutsopoulos HM , et al. Preliminary criteria for the classification of Sjögren′s syndrome. Results of a prospective concerted action supported by the European Community[J]. Arthritis Rheum, 1993,36(3):340-347.
doi: 10.1002/art.1780360309 pmid: 8452579
[14] Vitali C, Bombardieri S, Jonsson R , et al. Classification criteria for Sjögren′s syndrome: a revised version of the European criteria proposed by the American-European Consensus Group[J]. Ann Rheum Dis, 2002,61(6):554-558.
[15] Shiboski SC, Shiboski CH, Criswell LA , et al. American college of rheumatology classification criteria for sjögren′s syndrome: a data-driven, expert consensus approach in the sjögren′s international collaborative clinical alliance cohort[J]. Arthritis Care Res (Hoboken), 2012,64(4):475-487.
doi: 10.1002/acr.21591 pmid: 22563590
[16] Shiboski CH, Shiboski SC, Seror R , et al. 2016 American college of rheumatology/European league against rheumatism classification criteria for primary sjögren′s syndrome: a consensus and data-driven methodology involving three international patient cohorts[J]. Ann Rheum Dis, 2017,69(1):35-45.
[17] An BE, Akpek EK, Alevizos I , et al. 14th international symposium on sjögren′s syndrome[J]. Clin Exp Rheumatol, 2018,36(3):241-255.
[18] Shen L, Autoantibodies SL . Detection methods and panels for diagnosis of sjögren′s syndrome[J]. Clin Immunol, 2017,182:24-29.
[19] Bowman SJ, Fox RI . Classification criteria for Sjögren′s syndrome:nothing ever stands still![J]. Ann Rheum Dis, 2014,73(1):1-2.
doi: 10.1136/annrheumdis-2013-203953 pmid: 24092418
[20] Rasmussen A, Ice JA, Li H , et al. Comparison of the American-European consensus group sjögren′s syndrome classification criteria to newly proposed American college of rheumatology criteria in a large, carefully characterised sicca cohort[J]. Ann Rheum Dis, 2014,73(1):31-38.
doi: 10.1136/annrheumdis-2013-203845
[21] Billings M, Amin HM, Alevizos I . Comparative analysis of the 2016 ACR-EULAR and the 2002 AECG classification criteria for Sjögren′s syndrome: Findings from the NIH cohort[J]. Oral Dis, 2018,24(1/2):184-190.
doi: 10.1111/odi.12772
[22] Seror R, Bootsma H, Saraux A , et al. Defining disease activity states and clinically meaningful improvement in primary Sjögren′s syndrome with EULAR primary Sjögren′s syndrome disease activity (ESSDAI) and patient-reported indexes (ESSPRI)[J]. Ann Rheum Dis, 2016,75(2):382-389.
[23] Kongsted A, Nielsen AM . Latent class analysis in health research[J]. J Physiother, 2017,63(1):55-58.
doi: 10.1016/j.jphys.2016.05.018 pmid: 27914733
[24] Mariette X, Criswell LA . Primary sjögren′s syndrome[J]. N Engl J Med, 2018,378(10):931-939.
[25] Seror R, Ravaud P, Mariette X , et al. EULAR sjögren′s syndrome patient reported index(ESSPRI): development of a consensus patient index for primary sjögren′s syndrome[J]. Ann Rheum Dis, 2011,70(6):968-972.
doi: 10.1136/ard.2010.143743 pmid: 21345815
[26] Vitali C, Bombardieri S, Moutsopoulos HM , et al. Assessment of the European classification criteria for Sjögren′s syndrome in a series of clinically defined cases: results of a prospective multicentre study. The European Study Group on Diagnostic Criteria for Sjögren′s Syndrome[J]. Ann Rheum Dis, 1996,55(2):116-121.
[27] Zhu WY, Hu FC, Liu XG , et al. Role of the accessory parotid gland in the etiology of parotitis: statistical analysis of sialographic features[J]. PLoS One, 2016,11(2):e0150212.
doi: 10.1371/journal.pone.0150212 pmid: 4767724
[28] Wang DH, Fu HJ, Zeng RS , et al. Changes of mandibular movement tracings after the correction of mandibular protrusion by bilateral sagittal split ramus osteotomy[J]. J Oral Maxillofac Surg, 2009,67(10):2238-2244.
doi: 10.1016/j.joms.2009.04.075 pmid: 19761919
[29] Le Goff M, Cornec D, Jousse-Joulin SA , et al. Comparison of 2002 AECG and 2016 ACR/EULAR classification criteria and added value of salivary gland ultrasonography in a patient cohort with suspected primary Sjögren′s syndrome[J]. Arthritis Res Ther, 2017,19(1):269.
doi: 10.1186/s13075-017-1475-x pmid: 29208023
[30] Turnaoglu H, Kural RF, Pamukcu M , et al. Diagnostic value of acustic radiation force impulse imaging in the assessment of salivary gland involvement in primary Sjögren′s sydrome[J]. Med Ultrason, 2018,20(3):313-318.
[31] 陶谦, 朱王勇 . 一种用于采集人体单个大唾液腺分泌唾液的装置: CN206675542U[P]. 2017 -11-28.
[32] Kuklinski E, Asbell PA . Sjögren′s syndrome from the perspective of ophthalmology[J]. Clin Immunol, 2017,182(SI):55-61.
doi: 10.1016/j.clim.2017.04.017 pmid: 28476437
[33] Whitcher JP, Shiboski CH, Shiboski SC , et al. A simplified quantitative method for assessing keratoconjunctivitis sicca from the sjögren′s syndrome international registry[J]. Am J Ophthalmol, 2010,149(3):405-415.
doi: 10.1016/j.ajo.2009.09.013 pmid: 20035924
[34] Tong L, Koh V, Thong BY . Review of autoantigens in Sjögren′s syndrome: an update[J]. J Inflamm Res, 2017,10:97-105.
[35] Baer AN, Mcadams DM, Shiboski SC , et al. The SSB-positive/SSA-negative antibody profile is not associated with key phenotypic features of Sjögren′s syndrome[J]. Ann Rheum Dis, 2015,74(8):1557-1561.
doi: 10.1136/annrheumdis-2014-206683 pmid: 25735642
[36] Kyriakidis NC, Kapsogeorgou EK, Tzioufas AG . A comprehensive review of autoantibodies in primary Sjögren′s syndrome: clinical phenotypes and regulatory mechanisms[J]. J Autoimmun, 2014,51:67-74.
doi: 10.1016/j.jaut.2013.11.001 pmid: 24333103
[37] 董怡, 赵岩, 郭晓萍 , 等. 原发性干燥综合征诊断标准的初步研究[J]. 中华内科杂志, 1996,35(2):43-46.
doi: 10.1007/BF02951625
[38] 中华医学会风湿病学分会. 干燥综合征诊治指南(草案)[J]. 中华风湿病学杂志, 2003,7(7):446-448.
doi: 10.3760/j:issn:1007-7480.2003.07.019
[39] 中华医学会风湿病学分会. 干燥综合征诊断及治疗指南[J]. 中华风湿病学杂志, 2010,14(11):766-768.
doi: 10.3760/cma.j.issn.1007-7480.2010.11.011
[40] Mandal SK, Sandhya P, Kabeerdoss J , et al. CXCL13 levels in serum but not in saliva are elevated in Asian Indian patients with primary Sjögren′s syndrome[J]. Rheumatol Int, 2018,38(5):831-836.
doi: 10.1007/s00296-018-4006-4 pmid: 29541901
[41] Guggino G, Lin X, Rizzo A , et al. Interleukin-25 axis is involved in the pathogenesis of human primary and experimental murine sjögren′s syndrome[J]. Arthritis Rheumatol, 2018,70(8):1265-1275.
doi: 10.1002/art.40500
[42] Liang PS, Zhu WY, Lan TJ , et al. Detection of salivary protein biomarkers of saliva secretion disorder in a primary Sjögren′s syndrome murine model[J]. J Pharm Biomed Anal, 2018,154:252-262.
doi: 10.1016/j.jpba.2018.03.023 pmid: 29558726
[43] Jonsson R, Brokstad KA, Jonsson MV , et al. Current concepts on Sjögren′s syndrome-classification criteria and biomarkers[J]. Eur J Oral Sci, 2018,126(Suppl 1):37-48
doi: 10.1111/eos.12536 pmid: 30178554
[1] Yuanhong LI, Xinyi FANG, Yu QIU, Lei CHENG. Experimental study on the effects of green tea on salivary flow rate and pH value [J]. Journal of Prevention and Treatment for Stomatological Diseases, 2017, 25(9): 560-564.
[2] Wei-ni XIN, Zhi-duo HOU, Yao GONG. Relationship of clinical index between rheumatoid arthritis and chronic periodontitis [J]. Journal of Prevention and Treatment for Stomatological Diseases, 2017, 25(4): 227-230.
Viewed
Full text


Abstract

Cited
  Shared   
  Discussed   
[1] Hong-chang LAI,Jun-yu SHI. Maxillary sinus floor elevation[J]. Journal of Prevention and Treatment for Stomatological Diseases, 2017, 25(1): 8 -12 .
[2] Pin ZHOU, Yang-fei LI. MRI study of temporomandibular joint disc position in asymptomatic volunteers[J]. Journal of Prevention and Treatment for Stomatological Diseases, 2017, 25(4): 239 -244 .
[3] Xinxin XIA, Fang FANG, Lijuan CHENG. Shaping ability of Pathfile and WaveOne in simulated root canals[J]. Journal of Prevention and Treatment for Stomatological Diseases, 2017, 25(6): 365 -368 .
[4] Yuanhong LI, Xinyi FANG, Yu QIU, Lei CHENG. Experimental study on the effects of green tea on salivary flow rate and pH value[J]. Journal of Prevention and Treatment for Stomatological Diseases, 2017, 25(9): 560 -564 .
[5] Chengzhang LI. Masticatory muscles in occlusion[J]. Journal of Prevention and Treatment for Stomatological Diseases, 2017, 25(12): 755 -760 .
[6] . [J]. Journal of Prevention and Treatment for Stomatological Diseases, 2018, 26(1): 1 .
[7] Zhirong WU, Shiguang Huang. Research progress on the etiology, clinical examination and treatment of peri-implantitis[J]. Journal of Prevention and Treatment for Stomatological Diseases, 2018, 26(6): 401 -405 .
[8] Xiaowu YAO, Shisheng CHEN, Zizheng LU, Minxiao LIN. Clinical report and literature review on the amyloidosis of salivary glands[J]. Journal of Prevention and Treatment for Stomatological Diseases, 2018, 26(8): 533 -536 .
[9] Lan LIAO, Lijun ZENG. Updated research on digitalization in aesthetic restoration[J]. Journal of Prevention and Treatment for Stomatological Diseases, 2018, 26(7): 409 -414 .
[10] Yu LU, Chengxia LIU, Zhongjun LIU. Role of TRAF6 in inflammatory responses of human osteoblast-like cells with Enterococcusfaecalis[J]. Journal of Prevention and Treatment for Stomatological Diseases, 2017, 25(7): 420 -425 .

Copyright © Editorial Board of Journal of Prevention and Treatment for Stomatological Diseases

This work is licensed under a Creative Commons Attribution 3.0 License.

Address:Guangzhou City Jiangnan Road South 366, Editorial office ofJournal of Prevention and Treatment for Stomatological Diseases, zip code: 510280　Fax:020-34304115　E-mail：kqjbfz@vip.126.com

Supported by:Beijing Magtech

This work is licensed under a Creative Commons Attribution 3.0 License.